The registry aims to document epidemiologic data, treatment and long-term outcome as well as quality of life of patients with APL. Additionally, a biobanking project for further translational studies is integrated. Prospective population-based non-interventional and non-randomized multicenter registry.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
epidemiological parameters
Timeframe: yearly follow up for 5 years
diagnostic quality indicators
Timeframe: yearly follow up for 5 years
type of therapy
Timeframe: yearly follow up for 5 years
response, recurrence and time of death and resulting outcomes RFS and OS
Timeframe: yearly follow up for 5 years
Uwe Platzbecker, Prof. Dr.